Kent A Lehman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1521 W Main St, Berne, IN 46711 Phone: 260-589-3993 Fax: 260-589-2070 |
Robert Eugene Judge, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1521 W Main St, Suite 1, Berne, IN 46711 Phone: 260-589-2312 Fax: 260-589-3941 |
News Archive
Statins continue to show that their benefits extend beyond their original focus of lowering high cholesterol. With the increasing prevalence of asthma, scientists are studying the effects of statins in the lungs.
The DNA contained within each of our cells is exactly the same, yet different types of cells - skin cells, heart cells, brain cells - perform very different functions. The ultimate fate of these cells is encoded not just in the DNA, but in a specific pattern of chemical modifications that overlay the DNA structure.
More than six per cent of bowel cancer patients in Scotland died within 30 days of diagnosis according to new research published in the British Journal of Cancer.
Use of either proximal embolic protection devices (P-EPDs) or distal filter embolic protection devices (F-EPDs) during elective carotid artery stenting results in low rates of in-hospital stroke and death, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued non-final Actions Closing Prosecution in the reexamination proceedings for U.S. Pat. Nos. 6,833,252 ("the ‘252 patent") and 7,214,536 ("the ‘536 patent") that are owned by the Institut Pasteur and the Universite Pierre et Marie Cure (UPMC), and licensed to Cellectis, SA (ALCLS). For the second time, the PTO has rejected all claims under consideration as lacking novelty and/or as obvious in view of a variety of references, including many that were not provided to the patent examiners during prosecution by the patent applicants.
› Verified 6 days ago